Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The B cell receptor (BCR) is a complex, membrane-bound protein structure found on the surface of B lymphocytes (B cells). It plays a central role in the adaptive immune response by recognizing specific antigens, initiating signaling cascades that activate the B cell, and mediating antigen internalization for processing and presentation to helper T cells. The BCR is composed of membrane-bound immunoglobulin (mIg) and signal transduction subunits (CD79A/Igα and CD79B/Igβ). Upon antigen binding, ITAM motifs on CD79A/B are phosphorylated, triggering downstream signaling pathways involving Syk kinase, phospholipase C-γ2 (PLC-γ2), PI3K, Bruton’s tyrosine kinase (BTK), ultimately leading to changes in gene expression required for activation or differentiation. Aberrant activation or dysregulation of the BCR pathway contributes to hematologic malignancies, making it a therapeutic target.
Inhibition of downstream signaling pathways (e.g., BTK, PI3K, SYK) activated by BCR engagement.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B Cell Receptor (None).